Our business ethos is unique: Our revenues serve the National Health Service and St George’s University of London, fund basic research, support charities or otherwise are reinvested in the business. Our business is sustainable, adaptive to change and is led by the same specialists who founded the business more than ten years ago.
All our sponsors are preferred clients. Richmond Pharmacology’s interaction with its sponsors is personal and truly strategic, generating enhanced value for drug developers and investors.
Our work is closely supervised throughout by the same senior specialists sponsors meet during the first consultation or bid defence. Our services span strategic consultancy and concept development through to final reporting, utilising our many years of experience and leading to successful clinical trials with meaningful results.
Dr Jorg Taubel will be attending the ACCP in San Diego, September 17-19, where he will be discussing his latestRead more ›
Richmond Pharmacology is a frequent contributor and recognised thought leader for various scientific meetingsRead more ›
Richmond Pharmacology has been settling into life in its New London Bridge Research Unit.Read more ›